Skip to content

Clinical study on the effect of Chinese herbal medicine on high-risk population of COVID-19

Clinical study on the effect of Chinese herbal medicine on high-risk population of COVID-19

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200061628
Enrollment
Unknown
Registered
2022-06-29
Start date
2022-06-15
Completion date
Unknown
Last updated
2023-04-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Corona Virus Disease 2019

Interventions

Treatment group:Chinese medicine preventive granule (high dose)
Control group:Chinese medicine preventive granule (low dose)

Sponsors

Tianjin University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
5 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Close and sub-close contacts of COVID-19 infected persons; 2. Aged 5-80 years; 3. Informed consent of patients.

Exclusion criteria

Exclusion criteria: 1. Accompanied by serious underlying diseases affecting survival, including uncontrolled and clinically significant heart, kidney, digestive, blood diseases, neuropsychiatric diseases, immune diseases, metabolic diseases, malignant tumors, severe malnutrition, etc.; 2. Allergic constitution, allergic to the drug components involved in the treatment plan; 3. Pregnant or lactating women; 4. Unable to cooperate in mental state, suffering from mental diseases, having no self-control and unable to express themselves clearly; 5. Participating in other clinical trials; 6. According to the judgment of the investigator, there will be patients whose efficacy and safety evaluation will be affected by complications of enrollment or poor compliance.

Design outcomes

Primary

MeasureTime frame
Positive rate of virus nucleic acid test;

Secondary

MeasureTime frame
Rate of symptoms;rate of severe disease;

Countries

China

Contacts

Public ContactZhang Junhua

Tianjin University of Traditional Chinese Medicine

zjhtcm@foxmail.com+86 18920514315

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026